Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice

Journal of Medical Microbiology

Volumn 49, Issue 10, 2000, Pages 905-910

  Suzuki, K ^a   Tateda, K ^a   Matsumoto, T ^a   Gondaira, F ^a   Tsujimoto, S ^a   Yamaguchi, K ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; IMMUNE RESPONSE; INFLAMMATION; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI;

EID: 0033798478     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-10-905     Document Type: Article

References (20)

1. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
2. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype
3. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells
4. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933
5. Shiga and Shiga-like toxins
6. Shiga toxin-associated hemolytic-uremic syndrome: Combined cytotoxic effects of shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro
7. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cell: Implications for the pathogenesis of the hemolytic uremic syndrome
8. Purified shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages
9. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome
10. Modulation of host response to Escherichia coli O157:H7 infection by anti-CD18 antibody in rabbits
11. Neutrophil-mediated endothelial injury in haemolytic uremic syndrome
12. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin
13. Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli)
14. Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection
15. Plasma cytokine levels in hemolytic uremic syndrome
16. Interleukin-8 and polymorphoneutrophil leucocyte activation hemolytic uremic syndrome of childhood
17. The role of lipopolysaccharide and shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection
18. Bacterial endotoxin both enhances and inhibits the toxicity of shiga-like toxin II in rabbits and mice
19. The histopathology of the hemolytic uremic syndrome associated with verotoxin-producing Escherichia coli infections
20. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7